O-GlcNAc transferase regulates H 2 O 2 production via p38 MAPK
Preprint
Abstract
I. Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by augmented transforming growth factor-β (TGF-β) signaling leading to excessive extracellular matrix (ECM) deposition. The fibroblast-to-myofibroblast-transition (FMT) and metabolic reprogramming of lung fibroblasts (HLFs) are essential to IPF pathogenesis, yet the connection between nutrient metabolism and fibrogenesis remains poorly defined. The O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) is a nutrient-sensitive enzyme that adds O-GlcNAc moieties to substrates. We previously showed that loss of OGT reverses bleomycin-induced pulmonary fibrosis in mice. Here, using unbiased kinomics, we show that pharmacologic inhibition of OGT suppressed non-canonical TGF-β-induced mitogen-activated protein kinase (MAPK) signaling. Molecular confirmation revealed that TGF-β-induced phosphorylation of p38, but not ERK or JNK, was reduced by OGT blockade. Furthermore, p38 itself was O-GlcNAc-modified, which enhanced its phosphorylation and promoted downstream phosphorylation of the NADPH oxidase subunit, p47 phox . Inhibition of OGT, p38, or p47 phox reduced reactive oxygen species (ROS) in HLFs, revealing a previously unknown role of OGT-p38-p47 phox signaling in ROS production. Collectively, this work establishes that O-GlcNAc-modified p38 enhances p47 phox -dependent H 2 O 2 production. Highlights: Using PamChip STK arrays, we show that OGT inhibition causes broad kinomic remodeling, including suppression of non-canonical TGF-β MAPKs and multiple CDKs. OGT blockade selectively attenuates p38 phosphorylation, despite TGF-β-induced substrate redundancy with ERK and JNK. We provide evidence that p38 MAPK undergoes O-GlcNAcylation in human lung fibroblasts, a modification not previously reported. The study identifies a new signaling axis where O-GlcNAc modification of p38 modulates the phosphorylation of p47 phox , therefore regulating NOX-dependent H 2 O 2 production. Blocking OGT or inhibiting p38/p47 phox dramatically reduces TGF-β-driven H 2 O 2 production in human lung fibroblasts. GraphicalKeywords
This publication has 45 references indexed in Scilit:
- Interstitial Lung DiseaseJAMA, 2024
- Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosisBiomedicine & Pharmacotherapy, 2023
- The extracellular matrix and mechanotransduction in pulmonary fibrosisThe International Journal of Biochemistry & Cell Biology, 2020
- Idiopathic Pulmonary Fibrosis: New and Emerging Treatment OptionsDrugs & Aging, 2019
- Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?Drugs, 2016
- O-GlcNAcylation of kinasesBiochemical and Biophysical Research Communications, 2012
- Targeting NOX enzymes in pulmonary fibrosisCellular and Molecular Life Sciences, 2012
- A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivoNature Chemical Biology, 2008
- NADPH oxidase in human lung fibroblastsJournal of Biomedical Science, 2004
- The functional expression of p47‐phox and p67‐phox may contribute to the generation of superoxide by an NADPH oxidase‐like system in human fibroblastsFEBS Letters, 1994